Peter G. Traber - Dec 8, 2021 Form 4 Insider Report for SELECTA BIOSCIENCES INC (SELB)

Role
Chief Medical Officer
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Peter G. Traber
Stock symbol
SELB
Transactions as of
Dec 8, 2021
Transactions value $
$0
Form type
4
Date filed
12/10/2021, 04:07 PM
Previous filing
Oct 15, 2021
Next filing
Dec 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SELB Common Stock Award $0 +13.8K +8.89% $0.00 168K Dec 8, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 4, 2021, the reporting person was granted performance based restricted stock units for an aggregate of 27,500 shares of the Issuer's common stock (the "Performance RSUs"), which were earned based on the achievement of two separate performance conditions related to the Issuer's operating and research and development activities. The compensation committee of the board of directors of the Issuer has determined that the second of the performance conditions has been met, and accordingly 13,750 Performance RSUs vested on December 8, 2021,